Home›Stock Screener›CARYSIL›Intrinsic Value

CARYSIL Intrinsic Value

CARYSIL intrinsic value. CARYSIL (CARYSIL) median intrinsic value is ₹1023.33 from 10 valuation models (range ₹283–₹2361), vs current price ₹944.55 — +8.3% upside (Trading Near Calculated Value), margin of safety 7.7%. Analyse CARYSIL shareholder distribution to track promoter, FII and institutional holdings.

Market Price (CMP)
₹944.55
Primary Intrinsic Value
₹478.56
Market Cap
₹566.7 Cr
+8.3% Upside
Median Value
₹1023.33
Value Range
₹283 - ₹2361
Assessment
Trading Near Calculated Value
Safety Margin
7.7%

CARYSIL Valuation Methods Summary — DCF, Graham Number & P/E

CARYSIL intrinsic value across 10 models vs current price ₹944.55 — upside/downside and value range per method. For current market price and key ratios, visit CARYSIL share price chart.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹478.56 ₹382.85 - ₹574.27 -49.3% EPS: ₹39.88, Sector P/E: 12x
Book Value Method asset ₹1023.33 ₹921.00 - ₹1125.66 +8.3% Book Value/Share: ₹1023.33, P/B: 1.0x
Revenue Multiple Method revenue ₹1493.33 ₹1344.00 - ₹1642.66 +58.1% Revenue/Share: ₹1866.67, P/S: 0.8x
EBITDA Multiple Method earnings ₹1889.10 ₹1700.19 - ₹2078.01 +100.0% EBITDA: ₹224.00Cr, EV/EBITDA: 6x
Simple DCF (5Y) dcf ₹2361.38 ₹1889.10 - ₹2833.66 +150.0% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹283.36 ₹255.02 - ₹311.70 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹328.61 ₹295.75 - ₹361.47 -65.2% Revenue Growth: 6.0%, Adj P/E: 8.2x
ROE Based Valuation profitability ₹1889.10 ₹1700.19 - ₹2078.01 +100.0% ROE: 18.9%, P/E Multiple: 14x
Graham Defensive Method conservative ₹958.25 ₹862.43 - ₹1054.08 +1.5% EPS: ₹39.88, BVPS: ₹1023.33
Dividend Yield Method dividend ₹283.36 ₹255.02 - ₹311.70 -70.0% DPS: ₹3.00, Target Yield: 3.5%
Method Types: Earnings Asset DCF Growth Dividend Conservative

CARYSIL Intrinsic Value vs Market Price — All Valuation Models

CARYSIL fair value range ₹283–₹2361 vs current market price ₹944.55 across 10 valuation models. Browse CARYSIL financial statements for revenue, profit, balance sheet and cash flow data.

CARYSIL Intrinsic Value Analysis — Undervalued or Overvalued?

CARYSIL median intrinsic value ₹1023.33, current price ₹944.55 — Trading Near Calculated Value by 8.3%, margin of safety 7.7%.

What is the intrinsic value of CARYSIL?

Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of CARYSIL (CARYSIL) is ₹1023.33 (median value). With the current market price of ₹944.55, this represents a +8.3% variance from our estimated fair value.

The valuation range spans from ₹283.36 to ₹2361.38, indicating ₹283.36 - ₹2361.38.

Is CARYSIL undervalued or overvalued?

Based on our multi-method analysis, CARYSIL (CARYSIL) appears to be trading near calculated value by approximately 8.3%.

CARYSIL Financial Health — Key Ratios vs Industry Benchmarks

CARYSIL financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity 18.9% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 19.0% Industry Standard: 20%+ Above 10% Indicates operational efficiency level
Asset Turnover Ratio 1.07x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

CARYSIL Cash Flow Quality — Operating & Free Cash Flow

CARYSIL operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹109 Cr ₹65 Cr Positive Free Cash Flow 8/10
March 2025 ₹60 Cr ₹5 Cr Positive Free Cash Flow 7/10
March 2024 ₹53 Cr ₹5 Cr Positive Free Cash Flow 7/10
March 2023 ₹71 Cr ₹3 Cr Positive Free Cash Flow 7/10
March 2022 ₹52 Cr ₹16 Cr Positive Free Cash Flow 7/10